/wp-content/uploads/iEcure_logo.png
0
0
David Anderson
/wp-content/uploads/iEcure_logo.png
David Anderson2022-05-25 05:00:362022-05-25 08:00:43iECURE Enters Agreement with Center for Breakthrough Medicines (CBM) to Supply Materials for Future Clinical Programs
/wp-content/uploads/iEcure_logo.png
0
0
David Anderson
/wp-content/uploads/iEcure_logo.png
David Anderson2022-05-18 08:00:012022-05-18 08:16:53Nonhuman Primate Data from iECURE’s Knock-in In Vivo Gene Editing Approach for Deadly Urea Cycle Disorder to be Presented in Presidential Symposium at ASGCT 2022
/wp-content/uploads/iEcure_logo.png
0
0
David Anderson
/wp-content/uploads/iEcure_logo.png
David Anderson2022-05-02 19:02:112022-05-10 20:51:39iECURE Announces Presentation of Data on its Gene Editing Approach at the American Society of Cell and Gene Therapy Annual Meeting
/wp-content/uploads/iEcure_logo.png
0
0
David Anderson
/wp-content/uploads/iEcure_logo.png
David Anderson2022-04-25 07:00:042022-05-10 20:48:21iECURE Appoints George Diaz, M.D., Ph.D., as VP, Therapeutic Area Lead for Urea Cycle Disorders
/wp-content/uploads/iEcure_logo.png
0
0
David Anderson
/wp-content/uploads/iEcure_logo.png
David Anderson2022-02-01 08:11:062022-02-08 20:32:34iECURE Expands Leadership Team with the Appointment of Mark Semanick as VP and Head of Technical Operations and Brad Dickerson as VP of Project Management & Patient Advocacy
/wp-content/uploads/iEcure_logo.png
0
0
eallison
/wp-content/uploads/iEcure_logo.png
eallison2021-12-16 08:00:052022-05-10 20:07:18iECURE Partners to Develop Next-Generation Liver-Targeted Lipid Nanoparticles with University of Pennsylvania
/wp-content/uploads/iEcure_logo.png
0
0
eallison
/wp-content/uploads/iEcure_logo.png
eallison2021-12-07 12:29:012022-04-07 21:07:47iECURE Bolsters Senior Management Team with Appointment of David Garrett as Chief Financial Officer
/wp-content/uploads/iEcure_logo.png
0
0
eallison
/wp-content/uploads/iEcure_logo.png
eallison2021-09-15 08:00:302022-05-10 20:08:16iECURE Appoints Brian Di Donato to Board of Directors
/wp-content/uploads/iEcure_logo.png
0
0
eallison
/wp-content/uploads/iEcure_logo.png
eallison2021-09-15 08:00:072022-05-10 20:08:59iECURE Launches With $50 Million Series A Financing to Develop In Vivo Gene Insertion Approaches for Devastating Diseases
Scroll to top
